Niche heterogeneity influences the outcomes in myeloproliferative neoplasms
The reasons underlying the different pathogenesis and response to therapies in the myeloproliferative neoplasms have remained enigmatic. Grockowiak et al. provide some clues emerging from disease-specific alterations in the interaction of hematopoietic stem cells with their bone marrow niches (1).
